April 12, 2018 / 5:47 AM / 3 months ago

BRIEF-Mithra Pharmaceuticals Signs Principle Agreement For Estelle Commercialization In Canada With Searchlight Pharma

April 12 (Reuters) - MITHRA PHARMACEUTICALS SA:

* SIGNS PRINCIPLE AGREEMENT FOR ESTELLE COMMERCIALIZATION IN CANADA WITH SEARCHLIGHT PHARMA

* TOP LINE RESULTS FOR ESTELLE PHASE 3 TRIALS EXPECTED IN Q3 2018 AND Q1 2019

* ELIGIBLE TO RECEIVE UP TO EUR 15 MILLION IN UPFRONT PAYMENTS AND SALES-RELATED REVENUES

* TO MANUFACTURE ESTELLE FOR SEARCHLIGHT AND RECEIVE GUARANTEED ANNUAL RECURRING REVENUES

* THE ANNUAL RECURRING REVENUES TO BE BASED ON MINIMUM ANNUAL QUANTITIES

* AGREEMENT COULD ACHIEVE REVENUES OF AT LEAST EUR 50 MILLION FOR MITHRA Source text: bit.ly/2qoG2mt Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below